Takeda

Stepping up the fight to end HIV, TB and malaria among women and children

Total contribution

JPY 1.86 billion

Partner since

2010

Millions of lives are lost worldwide every year due to AIDS, tuberculosis (TB) and malaria, constituting a major obstacle to growth in developing countries. Africa suffers from a particularly severe shortage of health care providers, which hinders the provision of health care services to overcome these three diseases.

Antenatal and postnatal care are suitable entry points for the critical expansion of disease prevention, screening and treatment. However, the delivery of the recommended interventions during antenatal care, including screening, diagnosis and management of infectious diseases, remains below global targets.

Partnering with Takeda

Takeda has supported the Global Fund since 2010, making it the longest corporate partnership to date and an exemplary model of private sector engagement. Its financial support has helped strengthen the capacity of health workers in Kenya, Nigeria and Tanzania, and build resilient and sustainable health systems, a key strategic objective of the Global Fund.

Takeda’s first pledge of JPY 1 billion (approximately US$10 million) for 2010-2019 helped boost malaria prevention efforts in Tanzania with the distribution of mosquito nets, accelerated access to TB treatment in Kenya and expanded HIV services and awareness in Nigeria.

In 2019, Takeda became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment, pledging an additional JPY 1 billion over five years. This investment supports the improvement of maternal and child health by integrating quality HIV, TB and malaria services in antenatal and postnatal care in several priority countries in Africa.

In 2025, Takeda pledged JPY 350 million for the Global Fund’s Eighth Replenishment. This renewed commitment will support the scale and sustainability of the integrated care model for mothers over the next two years. This consistent, sustained support for health programs that are making a huge difference in people’s lives is testament to Takeda’s leadership and their deep understanding of how long-term commitments drive transformational change.

“For over 240 years, Takeda has prioritized patients and thoughtfully contributed to societal impact. Our long-standing collaboration with the Global Fund reflects this deeply rooted commitment. Through the Takeda Initiative, we have advanced systemic improvements in health care delivery for mothers and children in sub-Saharan Africa. With this renewed pledge, we remain committed to sustaining and scaling this impact by empowering local leadership and the health workforce for resilient health systems. Our contribution underscores the vital role of the private sector in tackling global health challenges and driving lasting change, in close collaboration with stakeholders.”
Takako Ohyabu, Chief Global Corporate Affairs and Sustainability Officer, Takeda Pharmaceutical Company